Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patients' Access to Treatments Act of 2015
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR, specialty pharmacy tiering restrictions. Regulatory implementation of a pathway for the approval of biosimilars. REMs. 340b program reform. policies placing restrictions on pharmacy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse, including Medicare lock-in programs. General issues dealing with regulating pharmacy drug compounding. HR 1600.
National Defense Authorization Act for Fiscal Year 2016
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2015 · second_quarter · Q2
Pharmacy issues related to the annual defense reauthorization (HR 1735,S 1376).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, White House Office
Source: Senate LDA
Pharmacy issues related to the annual defense reauthorization (HR 1735,S 1376).
National Defense Authorization Act for Fiscal Year 2016
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Pharmacy issues related to the annual defense reauthorization (HR 1735,S 1376).
American Research and Competitiveness Act of 2014
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Pharmacy issues related to the 2015 annual defense reauthorization (113th Congress - HR 4438)
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to FEHBP's pharmacy benefit (HR 1367). Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR. Specialty pharmacy tiering restrictions (HR 460). Regulatory implementation of a pathway for the approal of biosimilars. REMs. 340b program reform. Policies placing restrictions on pharmcy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act). S. 867, HR 4437, HR 4577.
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit design and pricing (MAC)issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to FEHBP's pharmacy benefit (HR 1367). Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR. Specialty pharmacy tiering restrictions (HR 460). Regulatory implementation of a pathway for the approal of biosimilars. REMs. 340b program reform. Policies placing restrictions on pharmcy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act). S. 867, HR 4437, HR 4577.
Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit design and pricing (MAC)issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
Generic Drug Pricing Fairness Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Generic Drug Pricing Fairness Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Generic Drug Pricing Fairness Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Generic Drug Pricing Fairness Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Generic Drug Pricing Fairness Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to FEHBP's pharmacy benefit (HR 1367). Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR. Specialty pharmacy tiering restrictions (HR 460). Regulatory implementation of a pathway for the approal of biosimilars. REMs. 340b program reform. Policies placing restrictions on pharmcy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act). S. 867, HR 4437, HR 4577.
American Research and Competitiveness Act of 2014
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Pharmacy issues related to the annual defense reauthorization (HR 4438)
Ensuring Seniors Access to Local Pharmacies Act of 2014
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Ensuring Seniors Access to Local Pharmacies Act of 2014
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Ensuring Seniors Access to Local Pharmacies Act of 2014
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Ensuring Seniors Access to Local Pharmacies Act of 2014
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to FEHBP's pharmacy benefit (HR 1367). Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR. Specialty pharmacy tiering restrictions (HR 460). Regulatory implementation of a pathway for the approal of biosimilars. REMs. 340b program reform. Policies placing restrictions on pharmcy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act). S. 867, HR 4437, HR 4577.
Ensuring Seniors Access to Local Pharmacies Act of 2014
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Patients' Access to Treatments Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Patients' Access to Treatments Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to FEHBP's pharmacy benefit (HR 1367). Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR. Specialty pharmacy tiering restrictions (HR 460). Regulatory implementation of a pathway for the approal of biosimilars. REMs. 340b program reform. Policies placing restrictions on pharmcy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act). S. 867, HR 4437, HR 4577.
Patients' Access to Treatments Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Patients' Access to Treatments Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Patients' Access to Treatments Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit design and pricing (MAC)issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to FEHBP's pharmacy benefit (HR 1367). Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR. Specialty pharmacy tiering restrictions (HR 460). Regulatory implementation of a pathway for the approal of biosimilars. REMs. 340b program reform. Policies placing restrictions on pharmcy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act). S. 867, HR 4437, HR 4577.
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
TRICARE Mail-Order Pharmacy Pilot Program Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
TRICARE Mail-Order Pharmacy Pilot Program Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act
TRICARE Mail-Order Pharmacy Pilot Program Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
TRICARE Mail-Order Pharmacy Pilot Program Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
National Defense Authorization Act for Fiscal Year 2011
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
National Defense Authorization Act for Fiscal Year 2011
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
National Defense Authorization Act for Fiscal Year 2011
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
To extend the temporary suspension of duty on artichokes, prepared or preserved otherwise than by vinegar or acetic acid, not frozen.
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
To extend the temporary suspension of duty on artichokes, prepared or preserved otherwise than by vinegar or acetic acid, not frozen.
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
To extend the temporary suspension of duty on artichokes, prepared or preserved otherwise than by vinegar or acetic acid, not frozen.
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act
To extend the temporary suspension of duty on artichokes, prepared or preserved otherwise than by vinegar or acetic acid, not frozen.
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
To amend the Harmonized Tariff Schedule of the United States to permit foreign jewelry manufacturers who purchase precious metals produced in the United States for use in the manufacture of jewelry abroad to pay import duties on the value of the imported jewelry articles less the value of all United States origin precious metals incorporated in the article.
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
To amend the Harmonized Tariff Schedule of the United States to permit foreign jewelry manufacturers who purchase precious metals produced in the United States for use in the manufacture of jewelry abroad to pay import duties on the value of the imported jewelry articles less the value of all United States origin precious metals incorporated in the article.
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
To amend the Harmonized Tariff Schedule of the United States to permit foreign jewelry manufacturers who purchase precious metals produced in the United States for use in the manufacture of jewelry abroad to pay import duties on the value of the imported jewelry articles less the value of all United States origin precious metals incorporated in the article.
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
TRICARE Mail-Order Pharmacy Pilot Program Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806--mail order demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program.
TRICARE Mail-Order Pharmacy Pilot Program Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806 Mail Order Demostration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R.3326, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2010
TRICARE Mail-Order Pharmacy Pilot Program Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806--Mail order demonstration program for TRICARE; Items related to implementing federal ceiling prices to prescription drugs dispensed at retail within the TRICARE program
TRICARE Mail-Order Pharmacy Pilot Program Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806--mail order demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program.
Early Treatment for HIV Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
H.R. 806 Mail Order Demostration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R.3326, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2010
Access to Life-Saving Medicine Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Access to Life-Saving Medicine Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Issues relating to the definition of Average Manufacture Price (AMP) as espoused by the Deficit Reduction Act Issues related to Medicare Part B and Part D: S. 870/HR 2567 to provide coverage of home infusion services and supplies under Medicare. Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/HR 976 (senate bill)); direct negotiation (HR 4/ S 1); electronic prescribing; various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/S. 2499)); direct negotiation (HR 4/ S 1); electronic prescribing (S2408/HR 4296); various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
Protecting Consumer Access to Generic Drugs Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Protecting Consumer Access to Generic Drugs Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
TRICARE Mail-Order Pharmacy Pilot Program Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Items related to fully funding the pharmacy benefit under the military health system--2008 Defense Authorization bills (HR 1585/S 1547/ HR 2986). Promoting TRICARE's mail order program--HR 2319 Items relating to the structure of the pharmacy benefit of the MHS and the implementation of federal pricing at retail.
TRICARE Mail-Order Pharmacy Pilot Program Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Items related to fully funding the pharmacy benefit under the military health system--2008 Defense Authorization bills (HR 1585/S 1547. Promoting TRICARE's mail order program--HR 2319 Items relating to the structure of the pharmacy benefit of the military health system
Medicare Home Infusion Therapy Coverage Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Issues relating to the definition of Average Manufacture Price (AMP) as espoused by the Deficit Reduction Act Issues related to Medicare Part B and Part D: S. 870/HR 2567 to provide coverage of home infusion services and supplies under Medicare. Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/HR 976 (senate bill)); direct negotiation (HR 4/ S 1); electronic prescribing; various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
340B Program Improvement and Integrity Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
340B Program Improvement and Integrity Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Issues relating to the definition of Average Manufacture Price (AMP) as espoused by the Deficit Reduction Act Issues related to Medicare Part B and Part D: S. 870/HR 2567 to provide coverage of home infusion services and supplies under Medicare. Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/HR 976 (senate bill)); direct negotiation (HR 4/ S 1); electronic prescribing; various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/S. 2499)); direct negotiation (HR 4/ S 1); electronic prescribing (S2408/HR 4296); various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
Food and Drug Administration Amendments Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Food and Drug Administration Amendments Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Prohibit Aid to Saudi Arabia Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Items related to fully funding the pharmacy benefit under the military health system--2008 Defense Authorization bills (HR 1585/S 1547/ HR 2986). Promoting TRICARE's mail order program--HR 2319 Items relating to the structure of the pharmacy benefit of the MHS and the implementation of federal pricing at retail.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/S. 2499)); direct negotiation (HR 4/ S 1); electronic prescribing (S2408/HR 4296); various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
Medicare Prescription Drug Price Negotiation Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Issues relating to the definition of Average Manufacture Price (AMP) as espoused by the Deficit Reduction Act Issues related to Medicare Part B and Part D: S. 870/HR 2567 to provide coverage of home infusion services and supplies under Medicare. Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/HR 976 (senate bill)); direct negotiation (HR 4/ S 1); electronic prescribing; various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/S. 2499)); direct negotiation (HR 4/ S 1); electronic prescribing (S2408/HR 4296); various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
Community Pharmacy Fairness Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Providing an antitrust exemption for pharmacies--HR 971/ S 885/ S. 2161
Community Pharmacy Fairness Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Providing an antitrust exemption for pharmacies--HR 971/ S 885
Lower Prices Reduced with Increased Competition and Efficient Development of Drugs Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Lower Prices Reduced with Increased Competition and Efficient Development of Drugs Act
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
340B Program Improvement and Integrity Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
340B Program Improvement and Integrity Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Biologics Price Competition and Innovation Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/S. 2499)); direct negotiation (HR 4/ S 1); electronic prescribing (S2408/HR 4296); various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Issues relating to the definition of Average Manufacture Price (AMP) as espoused by the Deficit Reduction Act Issues related to Medicare Part B and Part D: S. 870/HR 2567 to provide coverage of home infusion services and supplies under Medicare. Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/HR 976 (senate bill)); direct negotiation (HR 4/ S 1); electronic prescribing; various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
Community Pharmacy Fairness Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Providing an antitrust exemption for pharmacies--HR 971/ S 885/ S. 2161
Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/S. 2499)); direct negotiation (HR 4/ S 1); electronic prescribing (S2408/HR 4296); various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
Medicare, Medicaid, and SCHIP Extension Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/S. 2499)); direct negotiation (HR 4/ S 1); electronic prescribing (S2408/HR 4296); various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
Citizen Petition Fairness and Accuracy Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Citizen Petition Fairness and Accuracy Act of 2007
Client: EXPRESS SCRIPTS, INC. · Firm: EXPRESS SCRIPTS, INC.
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
2015 · first_quarter · Q1
Pharmacy issues related to the 2015 annual defense reauthorization (113th Congress - HR 4438)
Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR, specialty pharmacy tiering restrictions. Regulatory implementation of a pathway for the approval of biosimilars. REMs. 340b program reform. policies placing restrictions on pharmacy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse, including Medicare lock-in programs. General issues dealing with regulating pharmacy drug compounding. HR 1600.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2014 · fourth_quarter · Q4
Policies related to FEHBP's pharmacy benefit (HR 1367). Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR. Specialty pharmacy tiering restrictions (HR 460). Regulatory implementation of a pathway for the approal of biosimilars. REMs. 340b program reform. Policies placing restrictions on pharmcy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act). S. 867, HR 4437, HR 4577.
Pharmacy issues related to the annual defense reauthorization (HR 4438)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2014 · third_quarter · 3A
Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2014 · third_quarter · Q3
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2014 · second_quarter · 2A
Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2014 · second_quarter · Q2
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2014 · first_quarter · Q1
Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit design and pricing (MAC)issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2013 · fourth_quarter · Q4
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2013 · third_quarter · Q3
Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2013 · second_quarter · Q2
Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2013 · first_quarter · Q1
Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2012 · fourth_quarter · Q4
Pharmacy issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act of 2012--specifically promotion of House TMOP demonstration program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2012 · third_quarter · Q3
Pharmacy issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act of 2012--specifically promotion of House TMOP demonstration program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2012 · second_quarter · Q2
Pharmacy issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act of 2012.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2012 · first_quarter · Q1
Pharmacy issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act of 2012.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, U.S. Trade Representative (USTR), White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2011 · fourth_quarter · 4A
Pharmacy issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act of 2012.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, U.S. Trade Representative (USTR), White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2011 · fourth_quarter · Q4
Pharmacy issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act of 2012.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, U.S. Trade Representative (USTR), White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2011 · third_quarter · Q3
Issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act of 2012
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, U.S. Trade Representative (USTR), White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2011 · second_quarter · Q2
Issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act of 2012
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2011 · first_quarter · Q1
Issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act for 2012
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2010 · fourth_quarter · Q4
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2010 · third_quarter · Q3
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2010 · second_quarter · Q2
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2010 · first_quarter · Q1
H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2009 · fourth_quarter · Q4
H.R. 806 Mail Order Demostration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R.3326, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2010
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2009 · third_quarter · Q3
H.R. 806--mail order demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2009 · second_quarter · Q2
H.R. 806--mail order demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2009 · first_quarter · Q1
H.R. 806--Mail order demonstration program for TRICARE; Items related to implementing federal ceiling prices to prescription drugs dispensed at retail within the TRICARE program
Filing targets: Congressional Budget Office (CBO), Defense, Dept of (DOD), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2008 · fourth_quarter · Q4
Regulatory and Legislative items related to the structure and support of full funding of the military health care system. Regulatory implementation of federal pricing for prescription drugs at retail pharmacy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Legal Services Corporation, Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2008 · third_quarter · Q3
Items related to the structure of the pharmacy benefit of the military health system. Implementation of federal pricing for prescription drugs at retail pharmacy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2008 · second_quarter · Q2
Issues related to fully funding the pharmacy benefit under the military health care system--2009 Defense Authorization and Appropriations bills. Items related to the structure of the pharmacy benefit of the MHS and the implementation of federal pricing for prescription drugs at retail pharmacy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2008 · first_quarter · Q1
Items related to fully funding the pharmacy benefit under the military health care system--2009 Defense Authorization bills Items related to the structure of the pharmacy benefit of the MHS and the implementation of federal pricing for prescription drugs at retail pharmacy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2007 · year_end · YY
Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/S. 2499)); direct negotiation (HR 4/ S 1); electronic prescribing (S2408/HR 4296); various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
EXPRESS SCRIPTS, INC. via EXPRESS SCRIPTS, INC.
2007 · mid_year · MA
Providing an antitrust exemption for pharmacies--HR 971/ S 885
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Items related to fully funding the pharmacy benefit under the military health system--2008 Defense Authorization bills (HR 1585/S 1547. Promoting TRICARE's mail order program--HR 2319 Items relating to the structure of the pharmacy benefit of the military health system
Providing an antitrust exemption for pharmacies--HR 971/ S 885/ S. 2161
Items related to fully funding the pharmacy benefit under the military health system--2008 Defense Authorization bills (HR 1585/S 1547/ HR 2986). Promoting TRICARE's mail order program--HR 2319 Items relating to the structure of the pharmacy benefit of the MHS and the implementation of federal pricing at retail.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Issues relating to the definition of Average Manufacture Price (AMP) as espoused by the Deficit Reduction Act Issues related to Medicare Part B and Part D: S. 870/HR 2567 to provide coverage of home infusion services and supplies under Medicare. Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/HR 976 (senate bill)); direct negotiation (HR 4/ S 1); electronic prescribing; various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office